FGEN (FibroGen) Rega marang bathi mangsa ngarep
Low revenue predictability due to failures of key drugs creates risks for FibroGen, Inc. (FGEN), as illustrated by the company's forward P/E ratio on a precise GURU.Markets chart, where the latest parameter is 0.00. Patents for fibrosis therapy provide a stable cash flow, while revenue currently relies on Chinese royalties and the search for new market niches.
Ringkesan rincian data analitis FibroGen Corporation (FGEN)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal FibroGen, Inc.|FGEN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas FibroGen, Inc.|FGEN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku FibroGen Inc|FGEN - Kewajiban jangka dawa|Utang jangka cendhak perusahaan FibroGen|Rasio cepet fibrogen.com
- rincian asil keuangan lan kelipatan valuasi:
FGEN - Bathi resik perusahaan|Bathi sing dikarepake FibroGen, Inc.|FGEN - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep FibroGen Corp|FGEN - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA FibroGen Inc|FGEN - Bathi operasional sadurunge potongan amortisasi|Bathi resik saben saham (EPS TTM) FibroGen|FGEN - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan fibrogen.com|FGEN - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep FibroGen, Inc.
Pambiji fundamental:FibroGen
Forward P/E determines the stock price relative to expected net income, allowing for an assessment of the premium paid for future business growth. By analyzing the 12-month forward P/E of FibroGen, Inc. (FGEN), an investor can compare market expectations with the company's actual cash deficit, where restructuring and cost reductions become critical factors for achieving stated profitability targets.
Analisis pesaing FibroGen, Inc.
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio rega marang bathi sing dikarepake|ARS Pharma - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Theravance Corp TBPH|AQST: Pangali Forward P/E|SCPH (scPharmaceuticals) - Rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Tectonic Therapeutic Inc.|TNXP: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep China SXT Pharmaceuticals (SXTC)|EPRX - Rasio prakiraan rega marang bathi|Pangali Forward P/E BHST (BioHarvest Sciences)|Pangali forward rega marang bathi invizyne.com|Oramed Pharma - Pangali Forward P/E|Rasio prakiraan rega marang bathi Entera Bio Ltd.|MindWalk (HYFT) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep ABVC|Prakiraan rega marang bathi CPIX|QNTM: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Kapitalisasi marang proyeksi bathi ranitherapeutics.com|Rega marang bathi mangsa ngarep Synergy CHC SNYR|RLYB: Rasio rega marang bathi mangsa ngarep|Lexaria - Pangali Forward P/E|pulmatrix.com (PULM) - Prakiraan rega marang bathi|PTHL (ftzy.com.cn) - Prakiraan rega marang bathi|APM - Kapitalisasi marang proyeksi bathi|LYRA (Lyra Therapeutics, Inc) - Pangali Forward P/E|Impact BioMedical, Inc. - Rasio rega marang bathi sing dikarepake|Pangali Forward P/E TNFA|cbdmd.com (YCBD) - Pangali forward rega marang bathi|Pangali Forward P/E PRFX (PainReform)|Altamira Therapeutics Ltd (CYTO) - Rasio prakiraan rega marang bathi|LIPO - Rega marang bathi mangsa ngarep|OPTN (OptiNose Corp) - Rasio rega marang bathi mangsa ngarep|Pieris Pharmaceuticals (PIRS) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake PROC (procapsgroup.com)|PTPI (Petros Pharmaceuticals, Inc.) - Pangali Forward P/E|QLI: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E SLRN|Pangali Forward P/E TFF Pharmaceuticals, Inc (TFFP)
